Dimitri Krainc - Related publications

Northwestern University, Evanston, IL 
Cell Biology, Disease, Molecular Neuroscience, Neurobiology of Disease
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Li W, Fu Y, Halliday GM, Sue CM. Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson's Disease. Frontiers in Cell and Developmental Biology. 9: 612476. PMID 34295884 DOI: 10.3389/fcell.2021.612476   
2021 Troisi J, Landolfi A, Cavallo P, Marciano F, Barone P, Amboni M. Metabolomics in Parkinson's disease. Advances in Clinical Chemistry. 104: 107-149. PMID 34462054 DOI: 10.1016/bs.acc.2020.09.003   
2021 Amalric M, Pattij T, Sotiropoulos I, Silva JM, Sousa N, Ztaou S, Chiamulera C, Wahlberg LU, Emerich DF, Paolone G. Where Dopaminergic and Cholinergic Systems Interact: A Gateway for Tuning Neurodegenerative Disorders. Frontiers in Behavioral Neuroscience. 15: 661973. PMID 34366802 DOI: 10.3389/fnbeh.2021.661973   
2021 Lang A, Dassler E, Milenkovic I, Lutz MI, Kovacs GG. Variable expression of mitochondrial complex IV in the course of nigral intracellular accumulation of α-synuclein. Parkinsonism & Related Disorders. 90: 57-61. PMID 34385008 DOI: 10.1016/j.parkreldis.2021.08.001   
2021 Villavicencio Tejo F, Quintanilla RA. Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer's Disease. Antioxidants (Basel, Switzerland). 10. PMID 34356302 DOI: 10.3390/antiox10071069   
2021 Trudler D, Ghatak S, Lipton SA. Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases. International Journal of Molecular Sciences. 22. PMID 34360966 DOI: 10.3390/ijms22158196   
2021 Azam S, Haque ME, Balakrishnan R, Kim IS, Choi DK. The Ageing Brain: Molecular and Cellular Basis of Neurodegeneration. Frontiers in Cell and Developmental Biology. 9: 683459. PMID 34485280 DOI: 10.3389/fcell.2021.683459   
2021 Rahman MH, Bajgai J, Fadriquela A, Sharma S, Trinh TT, Akter R, Jeong YJ, Goh SH, Kim CS, Lee KJ. Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges. Molecules (Basel, Switzerland). 26. PMID 34500759 DOI: 10.3390/molecules26175327   
2021 Brooker SM, Krainc D. Glucocerebrosidase dysfunction in neurodegenerative disease. Essays in Biochemistry. PMID 34528667 DOI: 10.1042/EBC20210018   
2021 Venezia S, Kaufmann WA, Wenning GK, Stefanova N. Toll-like receptor 4 deficiency facilitates α-synuclein propagation and neurodegeneration in a mouse model of prodromal Parkinson's disease. Parkinsonism & Related Disorders. 91: 59-65. PMID 34530328 DOI: 10.1016/j.parkreldis.2021.09.007   
2021 Kim GH, Lee YC, Kim TJ, Kim ER, Hong SN, Chang DK, Kim YH. Risk of neurodegenerative diseases in patients with inflammatory bowel disease: a nationwide population-based cohort study. Journal of Crohn's & Colitis. PMID 34499125 DOI: 10.1093/ecco-jcc/jjab162   
2021 Zoey FL, Palanivel M, Padmanabhan P, Gulyás B. Parkinson's Disease: A Nanotheranostic Approach Targeting Alpha-Synuclein Aggregation. Frontiers in Cell and Developmental Biology. 9: 707441. PMID 34490255 DOI: 10.3389/fcell.2021.707441   
2021 Zhou S, Yu X, Wang M, Meng Y, Song D, Yang H, Wang D, Bi J, Xu S. Long Non-coding RNAs in Pathogenesis of Neurodegenerative Diseases. Frontiers in Cell and Developmental Biology. 9: 719247. PMID 34527672 DOI: 10.3389/fcell.2021.719247   
2021 Yu W, Ying J, Wang X, Liu X, Zhao T, Yoon S, Zheng Q, Fang Y, Yang D, Hua F. The Involvement of Lactosylceramide in Central Nervous System Inflammation Related to Neurodegenerative Disease. Frontiers in Aging Neuroscience. 13: 691230. PMID 34349634 DOI: 10.3389/fnagi.2021.691230   
2021 Drobny A, Ngo PA, Neurath MF, Zunke F, López-Posadas R. Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson's Disease. Frontiers in Medicine. 8: 655123. PMID 34368179 DOI: 10.3389/fmed.2021.655123   
2021 Guglietti B, Sivasankar S, Mustafa S, Corrigan F, Collins-Praino LE. Fyn Kinase Activity and Its Role in Neurodegenerative Disease Pathology: a Potential Universal Target? Molecular Neurobiology. PMID 34432266 DOI: 10.1007/s12035-021-02518-3   
2021 Yahi N, Di Scala C, Chahinian H, Fantini J. Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson's disease. Glycoconjugate Journal. PMID 34328594 DOI: 10.1007/s10719-021-10012-0   
2021 , Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, et al. Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. Jama. 326: 926-939. PMID 34519802 DOI: 10.1001/jama.2021.10207   
2021 Bugalho P, Ladeira F, Barbosa R, Marto JP, Borbinha C, da Conceição L, Salavisa M, Saraiva M, Meira B, Fernandes M. Progression in Parkinson's Disease: Variation in Motor and Non-motor Symptoms Severity and Predictors of Decline in Cognition, Motor Function, Disability, and Health-Related Quality of Life as Assessed by Two Different Methods. Movement Disorders Clinical Practice. 8: 885-895. PMID 34405096 DOI: 10.1002/mdc3.13262   
2021 Jan A, Gonçalves NP, Vaegter CB, Jensen PH, Ferreira N. The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses. International Journal of Molecular Sciences. 22. PMID 34361100 DOI: 10.3390/ijms22158338   
2021 Downs E, Bottrell AD, Naylor K. Identifying the Effects of Reactive Oxygen Species on Mitochondrial Dynamics and Cytoskeleton Stability in . Cells. 10. PMID 34440916 DOI: 10.3390/cells10082147   
2021 Dan X, Wechter N, Gray S, Mohanty JG, Croteau DL, Bohr VA. Olfactory dysfunction in aging and neurodegenerative diseases. Ageing Research Reviews. 101416. PMID 34325072 DOI: 10.1016/j.arr.2021.101416   
2021 Chang CH, Wei CC, Ho CT, Liao VH. N-γ-(L-glutamyl)-L-selenomethionine shows neuroprotective effects against Parkinson's disease associated with SKN-1/Nrf2 and TRXR-1 in Caenorhabditis elegans. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 92: 153733. PMID 34537465 DOI: 10.1016/j.phymed.2021.153733   
2021 Wang C, Lau CY, Ma F, Zheng C. Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34413194 DOI: 10.1073/pnas.2106504118   
2021 Johnson ME, Bergkvist L, Stetzik L, Steiner JA, Meyerdirk L, Schulz E, Wolfrum E, Luk KC, Wesson DW, Krainc D, Brundin P. Heterozygous GBA D490V and ATP13a2 mutations do not exacerbate pathological α-synuclein spread in the prodromal preformed fibrils model in young mice. Neurobiology of Disease. 105513. PMID 34536552 DOI: 10.1016/j.nbd.2021.105513   
2021 Gregersen E, Betzer C, Kim WS, Kovacs G, Reimer L, Halliday GM, Thiel S, Jensen PH. Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity. Journal of Neuroinflammation. 18: 177. PMID 34399786 DOI: 10.1186/s12974-021-02225-9   
2021 Chen PC, Chung CC, Cheng YY, Chen WT, Hong CT, Chan L, Chien LN. Retinal Diseases and Parkinson Disease: A Population-Based Study. Frontiers in Neuroscience. 15: 679092. PMID 34526876 DOI: 10.3389/fnins.2021.679092   
2021 Xiromerisiou G, Bourinaris T, Houlden H, Lewis PA, Senkevich K, Hammer M, Federoff M, Khan A, Spanaki C, Hadjigeorgiou GM, Bonstanjopoulou S, Fidani L, Ermolaev A, Gan-Or Z, Singleton A, et al. SORL1 mutation in a Greek family with Parkinson's disease and dementia. Annals of Clinical and Translational Neurology. PMID 34506082 DOI: 10.1002/acn3.51433   
2021 Xu S, Zhang X, Liu C, Liu Q, Chai H, Luo Y, Li S. Role of Mitochondria in Neurodegenerative Diseases: From an Epigenetic Perspective. Frontiers in Cell and Developmental Biology. 9: 688789. PMID 34513831 DOI: 10.3389/fcell.2021.688789   
2021 Dai L, Wang J, He M, Xiong M, Tian Y, Liu C, Zhang Z. Lovastatin Alleviates α-Synuclein Aggregation and Phosphorylation in Cellular Models of Synucleinopathy. Frontiers in Molecular Neuroscience. 14: 682320. PMID 34381332 DOI: 10.3389/fnmol.2021.682320   
2021 Tan LY, Yeo XY, Bae HG, Lee DPS, Ho RC, Kim JE, Jo DG, Jung S. Association of Gut Microbiome Dysbiosis with Neurodegeneration: Can Gut Microbe-Modifying Diet Prevent or Alleviate the Symptoms of Neurodegenerative Diseases? Life (Basel, Switzerland). 11. PMID 34357070 DOI: 10.3390/life11070698   
2021 Salahuddin P, Fatima MT, Uversky VN, Khan RH, Islam Z, Furkan M. The role of amyloids in Alzheimer's and Parkinson's diseases. International Journal of Biological Macromolecules. 190: 44-55. PMID 34480905 DOI: 10.1016/j.ijbiomac.2021.08.197   
2021 Katzeff JS, Kim WS. ATP-binding cassette transporters and neurodegenerative diseases. Essays in Biochemistry. PMID 34415015 DOI: 10.1042/EBC20210012   
2021 Xiong M, Qian Q, Liang X, Wei YD. Serum levels of lipocalin-2 in patients with Parkinson's disease. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 34455500 DOI: 10.1007/s10072-021-05579-3   
2021 Hung C, Livesey FJ. Endolysosome and autophagy dysfunction in Alzheimer disease. Autophagy. 1-2. PMID 34429033 DOI: 10.1080/15548627.2021.1963630   
2021 Wu PF, Zhang XH, Zhou P, Yin R, Zhou XT, Zhang W. Growth Differentiation Factor 15 Is Associated With Alzheimer's Disease Risk. Frontiers in Genetics. 12: 700371. PMID 34484296 DOI: 10.3389/fgene.2021.700371   
2021 Walkley SU. Rethinking lysosomes and lysosomal disease. Neuroscience Letters. 762: 136155. PMID 34358625 DOI: 10.1016/j.neulet.2021.136155   
2021 Balana AT, Pratt MR. Mechanistic roles for altered O-GlcNAcylation in neurodegenerative disorders. The Biochemical Journal. 478: 2733-2758. PMID 34297044 DOI: 10.1042/BCJ20200609   
2021 Preeti K, Sood A, Fernandes V. Metabolic Regulation of Glia and Their Neuroinflammatory Role in Alzheimer's Disease. Cellular and Molecular Neurobiology. PMID 34515874 DOI: 10.1007/s10571-021-01147-7   
2021 Jankowska-Kieltyka M, Roman A, Nalepa I. The Air We Breathe: Air Pollution as a Prevalent Proinflammatory Stimulus Contributing to Neurodegeneration. Frontiers in Cellular Neuroscience. 15: 647643. PMID 34248501 DOI: 10.3389/fncel.2021.647643   
2021 Sharma VK, Singh TG, Singh S, Garg N, Dhiman S. Apoptotic Pathways and Alzheimer's Disease: Probing Therapeutic Potential. Neurochemical Research. PMID 34386919 DOI: 10.1007/s11064-021-03418-7   
2021 Lotz SK, Blackhurst BM, Reagin KL, Funk KE. Microbial Infections Are a Risk Factor for Neurodegenerative Diseases. Frontiers in Cellular Neuroscience. 15: 691136. PMID 34305533 DOI: 10.3389/fncel.2021.691136   
2021 Ayeni EA, Gong Y, Yuan H, Hu Y, Bai X, Liao X. Medicinal plants for anti-neurodegenerative diseases in West Africa. Journal of Ethnopharmacology. 114468. PMID 34390796 DOI: 10.1016/j.jep.2021.114468   
2021 Chen PC, Yu CC, Chen YS, Lu CH, Chan SH, Chou KH, Chen MH, Chen MH, Lin WC. The Potential Effects of Oxidative Stress-Related Plasma Abnormal Protein Aggregate Levels on Brain Volume and Its Neuropsychiatric Consequences in Parkinson's Disease. Oxidative Medicine and Cellular Longevity. 2021: 3666327. PMID 34434484 DOI: 10.1155/2021/3666327   
2021 Mishra A, Bandopadhyay R, Singh PK, Mishra PS, Sharma N, Khurana N. Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside. Metabolic Brain Disease. PMID 34387831 DOI: 10.1007/s11011-021-00806-4   
2021 Richard P, Kozlowski L, Guillorit H, Garnier P, McKnight NC, Danchin A, Manière X. Queuine, a bacterial-derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration. Plos One. 16: e0253216. PMID 34379627 DOI: 10.1371/journal.pone.0253216   
2021 Ryu WI, Cohen BM, Sonntag KC. Hypothesis and Theory: Characterizing Abnormalities of Energy Metabolism Using a Cellular Platform as a Personalized Medicine Approach for Alzheimer's Disease. Frontiers in Cell and Developmental Biology. 9: 697578. PMID 34395428 DOI: 10.3389/fcell.2021.697578   
2021 Villanueva EB, Tresse E, Liu Y, Duarte JN, Jimenez-Duran G, Ejlerskov P, Kretz O, Loreth D, Goldmann T, Prinz M, Issazadeh-Navikas S. Neuronal TNFα, Not α-Syn, Underlies PDD-Like Disease Progression in IFNβ-KO Mice. Annals of Neurology. PMID 34476836 DOI: 10.1002/ana.26209   
2021 He L, Zhao R, Wang Y, Liu H, Wang X. Research Progress on Catalpol as Treatment for Atherosclerosis. Frontiers in Pharmacology. 12: 716125. PMID 34326774 DOI: 10.3389/fphar.2021.716125   
2021 Xu W, Duan L, Zheng H, Li-Ling J, Jiang W, Zhang Y, Wang T, Qin R. An Integrative Disease Information Network Approach to Similar Disease Detection. Ieee/Acm Transactions On Computational Biology and Bioinformatics. PMID 34478379 DOI: 10.1109/TCBB.2021.3110127